Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
?

?

-4.100%
-3.25
-4.100%
€59.65

€59.65

 
08:02 / Frankfurt WKN: 856744 / Symbol: CBT / Name: Cabot / Stock / Chemicals / Mid Cap /
Latest predictions
14.06.26
1.12%
buy
€84.98
08.06.26
6.37%
buy
€59.65
13.05.26
9.07%
10.01.26
22.22%
buy
08.01.26
24.19%
buy
€68.15
18.12.25
33.33%
buy
Best running prediction
€62.03
17.11.25
45.28%
buy
Your prediction

Cabot Corp. Stock

Heavy losses for Cabot Corp. today as the stock fell by -€3.250 (-4.100%).
With 6 Buy predictions and only 2 Sell predictions the community sentiment for the stock is positive.
On the other hand, the target price of 59 € is below the current price of 76.0 € for Cabot Corp., so the potential is actually -22.37%.

Pros and Cons of Cabot Corp. in the next few years

Pros
?
M***** P*******
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Cons
?
B****
?
S********** s********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Cabot Corp. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Cabot Corp. -4.100% 2.194% 0.699% 25.714% 41.429% 24.724% 72.174%
Innospec Inc. - 0.685% 3.521% 4.255% 11.364% -23.438% -
Sensient Technologies Corp. 1.890% 3.922% -0.935% 9.278% 32.500% 78.151% -
Stepan Co 10.780% 0.000% 7.595% 6.695% 28.141% -38.922% -48.485%

Comments

Cabot (CBT) was upgraded by Wall Street Zen from "hold" to "buy".
Ratings data for CBT provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 6.37%
Target price 84.976
Change
Ends at 08.06.27

Cabot (CBT) is now covered by Truist Financial Corporation. They set a "buy" rating and a $98.00 price target on the stock.
Ratings data for CBT provided by MarketBeat
Show more

Prediction Sell
Perf. (%) 9.07%
Target price 59.647
Change
Ends at 13.05.27

Cabot (CBT) had its price target raised by JPMorgan Chase & Co. from $68.00 to $70.00. They now have an "underweight" rating on the stock.
Ratings data for CBT provided by MarketBeat
Show more

News

Why a Fund Made a $3.5 Million Bet on This Flat Chemicals Stock With Declining Revenue and EarningsPhoto, wide shot, wide-angle lens, soft focus,  Quarry, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-YQuR80w6IvxjemEoWYDXbEZo.png?st=2023-10-15T10%3A03%3A37Z&se=2023-10-15T12%3A03%3A37Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-10-14T14%3A03%3A01Z&ske=2023-10-15T14%3A03%3A01Z&sks=b&skv=2021-08-06&sig=/3q45HS%2B7KQiNIRh0W63diwmt7u%2BeQQMkMTkhvmYMtE%3D
Why a Fund Made a $3.5 Million Bet on This Flat Chemicals Stock With Declining Revenue and Earnings

On April 22, 2026, 1492 Capital Management disclosed a new position in Cabot Corporation (NYSE:CBT), acquiring 48,057 shares in the first quarter. The estimated transaction value was $3.49 million